VEEV Stock Overview
Veeva Systems Inc. provides cloud-based software for the life sciences industry.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for VEEV from our risk checks.
Veeva Systems Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$199.54 |
| 52 Week High | US$236.90 |
| 52 Week Low | US$160.21 |
| Beta | 0.73 |
| 1 Month Change | -13.22% |
| 3 Month Change | -3.67% |
| 1 Year Change | 8.83% |
| 3 Year Change | -28.51% |
| 5 Year Change | 45.53% |
| Change since IPO | 436.98% |
Recent News & Updates
Veeva Systems: Strong Reasons To Buy And Hold The Shares
Apr 18Earnings Tell The Story For Veeva Systems Inc. (NYSE:VEEV)
Apr 15
Veeva Systems: A Jewel In Transition
Mar 28Veeva Systems: Still Attractively Priced Given Growth Expectations
Mar 13Recent updates
Veeva Systems: Strong Reasons To Buy And Hold The Shares
Apr 18Earnings Tell The Story For Veeva Systems Inc. (NYSE:VEEV)
Apr 15Veeva Systems: A Jewel In Transition
Mar 28Veeva Systems: Still Attractively Priced Given Growth Expectations
Mar 13Veeva: Growth Prospects Have Improved, But Stock Price May Be Capped
Mar 05Do Veeva Systems' (NYSE:VEEV) Earnings Warrant Your Attention?
Feb 15Veeva Systems (NYSE:VEEV) May Have Issues Allocating Its Capital
Jan 28Veeva Systems: Well Positioned To Consolidate Share In The Industry
Jan 24Veeva: Downside Risks Driven By Slowing Revenue, Uncertain Product Adoption And Increasing Competition
Jan 08Veeva Systems: A Recovery Might Be Sooner Than Later
Dec 22Veeva Systems Q3 Preview: Navigating Challenges And Opportunities For F2025
Nov 29Is There Now An Opportunity In Veeva Systems Inc. (NYSE:VEEV)?
Nov 29Veeva: Some Underappreciated Growth Opportunities
Oct 20Veeva Systems' (NYSE:VEEV) Returns On Capital Not Reflecting Well On The Business
Oct 16Veeva Systems: A Lot Of Growth Opportunities Remain
Oct 03Estimating The Intrinsic Value Of Veeva Systems Inc. (NYSE:VEEV)
Oct 02Veeva Systems: Its Strong Moat Might Extend To The SMB Sector
Sep 21Veeva Systems: A Close Look At Its Evolving Valuation
Sep 01Do Veeva Systems' (NYSE:VEEV) Earnings Warrant Your Attention?
Sep 01Should You Investigate Veeva Systems Inc. (NYSE:VEEV) At US$201?
Jul 31Veeva Systems: Cloud Dominance Counters Competition
Jul 26Capital Allocation Trends At Veeva Systems (NYSE:VEEV) Aren't Ideal
Jul 13Veeva Systems: Richly Priced For What It Offers
Jul 05Are Veeva Systems Inc. (NYSE:VEEV) Investors Paying Above The Intrinsic Value?
Jun 13Veeva Systems: AI Potential For Life Sciences Underappreciated
Jun 12Veeva Systems: Strengths Shine Through With Q1 Results
Jun 02Veeva Systems: Keep An Eye On The Following Things
May 23What Does Veeva Systems Inc.'s (NYSE:VEEV) Share Price Indicate?
May 02Veeva Systems (NYSE:VEEV) May Have Issues Allocating Its Capital
Apr 14Should You Be Adding Veeva Systems (NYSE:VEEV) To Your Watchlist Today?
Mar 17Veeva Systems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Mar 04Veeva Systems downgraded by Guggenheim on worries estimates are too high
Feb 23Veeva Systems: A Leading Provider Of Cloud-Based Solutions For The Pharmaceutical Industry
Jan 30Estimating The Intrinsic Value Of Veeva Systems Inc. (NYSE:VEEV)
Jan 24What Does Veeva Systems Inc.'s (NYSE:VEEV) Share Price Indicate?
Jan 09Veeva Systems: The Stock Is Not Expensive
Dec 30The Returns On Capital At Veeva Systems (NYSE:VEEV) Don't Inspire Confidence
Nov 26Veeva Systems: An Ambitious Goal Within Reach
Nov 09Veeva: Niche SaaS Doesn't Hit The Mark For Me
Oct 25What Is Veeva Systems Inc.'s (NYSE:VEEV) Share Price Doing?
Oct 08Veeva: A Dip Not Worth Buying
Oct 06Are Investors Undervaluing Veeva Systems Inc. (NYSE:VEEV) By 33%?
Sep 23Shareholder Returns
| VEEV | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -5.5% | -6.1% | -3.7% |
| 1Y | 8.8% | -11.9% | 20.2% |
Return vs Industry: VEEV exceeded the US Healthcare Services industry which returned -11.9% over the past year.
Return vs Market: VEEV underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| VEEV volatility | |
|---|---|
| VEEV Average Weekly Movement | 3.6% |
| Healthcare Services Industry Average Movement | 9.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VEEV has not had significant price volatility in the past 3 months.
Volatility Over Time: VEEV's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 7,172 | Peter Gassner | www.veeva.com |
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process.
Veeva Systems Inc. Fundamentals Summary
| VEEV fundamental statistics | |
|---|---|
| Market cap | US$32.20b |
| Earnings (TTM) | US$525.71m |
| Revenue (TTM) | US$2.36b |
61.3x
P/E Ratio13.6x
P/S RatioIs VEEV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VEEV income statement (TTM) | |
|---|---|
| Revenue | US$2.36b |
| Cost of Revenue | US$677.29m |
| Gross Profit | US$1.69b |
| Other Expenses | US$1.16b |
| Earnings | US$525.71m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.26 |
| Gross Margin | 71.35% |
| Net Profit Margin | 22.24% |
| Debt/Equity Ratio | 0% |
How did VEEV perform over the long term?
See historical performance and comparison